Company: DVAX
Filing Date: 2025-04-03
Form Type: PREC14A
Source: 0000930413-25-001153
Chunk: 76

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-04-03
Form: PREC14A
Chunk 76
---
,000 |     | $                 | 12.48 |     | $                  |   513,331 |     | 2.5%       |
| David F. Novack      |     | 2/15/2024     |     |               95,000 |     | $                 | 12.48 |     | $                  |   750,253 |     | 2.5%       |
| John L. Slebir       |     | 2/15/2024     |     |               70,000 |     | $                 | 12.48 |     | $                  |   552,818 |     | 2.5%       |
| Robert Janssen, M.D. |     | 2/15/2024     |     |               50,000 |     | $                 | 12.48 |     | $                  |   394,870 |     | 2.5%       |

| (1) | These stock option awards were granted at a regularly scheduled meeting of the Compensation Committee.                            |
| (2) | This represents the percentage change in the closing market price of the common stock between the trading day ending immediately  
 prior to the disclosure of material nonpublic information (February 22, 2024) and the trading day beginning immediately following 
 the disclosure of material nonpublic information (February 23, 2024). On February 22, 2024, we filed our Annual Report on         
 Form 10-K for the fiscal year ended December 31, 2023 and a current report on Form 8-K related to our financial results           
 for the fourth quarter and fiscal year ended December 31, 2023.                                                                   |

| 61 |

We encourage our NEOs to hold a significant equity
interest in our Company, but we have not set specific stock ownership guidelines.

Compensation Recovery Policy

In November 2023, we adopted the Dynavax Technologies
Corporation Incentive Compensation Recoupment Policy (the “Recoupment Policy”), which is intended to comply with the
Dodd Frank Wall Street Reform and Consumer Protection Act and related Nasdaq listing standards. A copy of the Recoupment Policy can be
found in the investors section of our website, www.dynavax.com under investors-corporate governance. In addition, as a public company
subject to the provisions of Section 304 of the Sarbanes-Oxley Act of